StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

SABS — SAB Biotherapeutics, Inc.

FAIR (MOS +12.3%) · Quality 40/100

Price
3.51
Intrinsic value
4
Margin of safety
+12.3%
Implied growth (reverse DCF)
-
a described calculation from stated inputs, not a forecast
Value Score
23.4
Quality
40
Psychology
8.4
Discovery
40.4
price/volume attention only
Moat score
0
erosion: none

Value Score: bottom 36% of Russell 3000 · Quality: bottom 25%

Open the interactive Deep Dive for SABS →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/SABS - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is SABS undervalued?

As of 2026-09-19, SABS trades at 3.51 against a computed intrinsic value of 4 (+12.3% margin of safety) - StocksDeepDive's valuation label for this is FAIR. This is a described calculation from public data, not a recommendation.

What is SAB Biotherapeutics, Inc.'s Value Score?

SAB Biotherapeutics, Inc.'s Value Score is 23.4 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.